Skip to main content
. 2023 Jul 31;15(7):377–383. doi: 10.14740/jocmr4987

Figure 1.

Figure 1

Effect of 24-week oral semaglutide treatment on glycemic control and serum liver enzymes. Data are expressed as mean ± SE. *P < 0.05. **P < 0.01, ***P < 0.001 vs. baseline and ##P < 0.01 vs. 12 weeks. HbA1c: hemoglobin A1c; AST: aspartate aminotransferase; ALT: alanine aminotransferase; SE: standard error.